| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | NEUTRAL | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 14.31▼ | 14.30▼ | 14.31▼ | 14.07▲ | 13.89▲ |
| MA10 | 14.31▼ | 14.31▼ | 14.29▼ | 13.82▲ | 14.27▲ |
| MA20 | 14.31▼ | 14.29▼ | 14.23▲ | 13.87▲ | 14.55▼ |
| MA50 | 14.32▼ | 14.17▲ | 13.94▲ | 14.34▼ | 14.36▼ |
| MA100 | 14.29▼ | 13.91▲ | 13.78▲ | 14.58▼ | 14.17▲ |
| MA200 | 14.23▲ | 13.80▲ | 13.90▲ | 14.59▼ | 14.54▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | -0.012▼ | -0.012▼ | 0.107▲ | -0.127▼ |
| RSI | 34.294▼ | 56.837▲ | 67.424▲ | 59.303▲ | 48.540▼ |
| STOCH | 53.333 | 29.422 | 56.161 | 83.733▲ | 22.731 |
| WILL %R | -100.000▼ | -58.333 | -40.385 | -8.451▲ | -51.852 |
| CCI | -220.528▼ | -42.295 | 30.650 | 135.995▲ | -52.443 |
|
Thursday, November 13, 2025 05:47 AM
Presented new subgroup analyses from phase 3 clinical trial of CAN-2409 in localized prostate cancer at the American Society for Radiation Oncology (ASTRO) 2025 meeting, demonstrating improved ...
|
|
Tuesday, November 11, 2025 08:51 AM
Neurocrine's Phase 2 trial of NBI-1070770 in major depressive disorder missed its main goal but showed good safety and strong Q3 financial results.
|
|
Tuesday, November 11, 2025 08:51 AM
Neurocrine's Phase 2 trial of NBI-1070770 in major depressive disorder missed its main goal but showed good safety and strong Q3 financial results.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/11/25 | 14.36 | 14.41 | 14.27 | 14.29 | 2,656,300 |
| 13/11/25 | 14.12 | 14.32 | 14.12 | 14.24 | 4,222,700 |
| 12/11/25 | 13.96 | 14.15 | 13.96 | 14.09 | 3,120,900 |
| 11/11/25 | 13.78 | 14.02 | 13.78 | 14.01 | 4,579,400 |
| 10/11/25 | 13.62 | 13.73 | 13.56 | 13.71 | 3,996,800 |
| 07/11/25 | 13.60 | 13.68 | 13.56 | 13.66 | 2,599,800 |
| 06/11/25 | 13.59 | 13.68 | 13.57 | 13.64 | 3,644,300 |
| 05/11/25 | 13.50 | 13.64 | 13.50 | 13.59 | 2,928,300 |
| 04/11/25 | 13.55 | 13.68 | 13.52 | 13.56 | 3,009,200 |
| 03/11/25 | 13.37 | 13.44 | 13.35 | 13.42 | 2,656,100 |
|
|
||||
|
|
||||
|
|